End-Payors, Direct Purchasers Get Cert. In Solodyn MDL
End-payor and direct purchasers' bids for class certification were granted in Massachusetts federal court Monday in the pay-for-delay litigation against drugmakers Medicis Pharmaceutical Corp. and Impax Laboratories Inc. over the generic...To view the full article, register now.
Already a subscriber? Click here to view full article